These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24841677)

  • 1. Multiple metabolomics of uropathogenic E. coli reveal different information content in terms of metabolic potential compared to virulence factors.
    AlRabiah H; Xu Y; Rattray NJ; Vaughan AA; Gibreel T; Sayqal A; Upton M; Allwood JW; Goodacre R
    Analyst; 2014 Sep; 139(17):4193-9. PubMed ID: 24841677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted metabolic profiling rapidly differentiates Escherichia coli and Staphylococcus aureus at species and strain level.
    Li H; Zhu J
    Rapid Commun Mass Spectrom; 2017 Oct; 31(19):1669-1676. PubMed ID: 28776775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification.
    Ohta D; Kanaya S; Suzuki H
    Curr Opin Biotechnol; 2010 Feb; 21(1):35-44. PubMed ID: 20171870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourier transform mass spectrometry for metabolome analysis.
    Junot C; Madalinski G; Tabet JC; Ezan E
    Analyst; 2010 Sep; 135(9):2203-19. PubMed ID: 20574587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liquid chromatography-mass spectrometry and direct infusion microchip electrospray ionization mass spectrometry in global metabolomics of cell samples.
    Pöhö P; Lipponen K; Bespalov MM; Sikanen T; Kotiaho T; Kostiainen R
    Eur J Pharm Sci; 2019 Oct; 138():104991. PubMed ID: 31404622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workflow methodology for rat brain metabolome exploration using NMR, LC-MS and GC-MS analytical platforms.
    Diémé B; Lefèvre A; Nadal-Desbarats L; Galineau L; Madji Hounoum B; Montigny F; Blasco H; Andres CR; Emond P; Mavel S
    J Pharm Biomed Anal; 2017 Aug; 142():270-278. PubMed ID: 28531831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxonomic Studies of Nine Gentianaceae Species from Western China Based on Liquid Chromatography Tandem Mass Spectrometry and Fourier Transform Infrared Spectroscopy.
    Pan Y; Zhang J; Zhao YL; Wang YZ; Jin H
    Phytochem Anal; 2016 May; 27(3-4):158-67. PubMed ID: 26919544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TiO
    Zhang R; Qin Q; Liu B; Qiao L
    Anal Chem; 2018 Mar; 90(6):3863-3870. PubMed ID: 29461808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of nanoscale LC-ESI for metabolomics and its potential to enhance the metabolome coverage.
    Chetwynd AJ; David A
    Talanta; 2018 May; 182():380-390. PubMed ID: 29501168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism.
    Su Q; Guan T; He Y; Lv H
    J Proteome Res; 2016 Apr; 15(4):1323-32. PubMed ID: 26954697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence.
    Lo AW; Moriel DG; Phan MD; Schulz BL; Kidd TJ; Beatson SA; Schembri MA
    Trends Microbiol; 2017 Sep; 25(9):729-740. PubMed ID: 28550944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast milk metabolome characterization in a single-phase extraction, multiplatform analytical approach.
    Villaseñor A; Garcia-Perez I; Garcia A; Posma JM; Fernández-López M; Nicholas AJ; Modi N; Holmes E; Barbas C
    Anal Chem; 2014 Aug; 86(16):8245-52. PubMed ID: 25058331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial metabolomics: A pilot mass spectrometry and NMR study of the human plasma metabolome in response to a challenge meal.
    Karimpour M; Surowiec I; Wu J; Gouveia-Figueira S; Pinto R; Trygg J; Zivkovic AM; Nording ML
    Anal Chim Acta; 2016 Feb; 908():121-31. PubMed ID: 26826694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.
    Henderson JP; Crowley JR; Pinkner JS; Walker JN; Tsukayama P; Stamm WE; Hooton TM; Hultgren SJ
    PLoS Pathog; 2009 Feb; 5(2):e1000305. PubMed ID: 19229321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From
    Liu W; Song Q; Cao Y; Xie N; Li Z; Jiang Y; Zheng J; Tu P; Song Y; Li J
    J Pharm Biomed Anal; 2019 Jan; 162():16-27. PubMed ID: 30219595
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.